These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 22056608)

  • 41. Involvement of central mu- but not delta- or kappa-opioid receptors in immunomodulation.
    Nelson CJ; Schneider GM; Lysle DT
    Brain Behav Immun; 2000 Sep; 14(3):170-84. PubMed ID: 10970678
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The nociceptin/orphanin FQ receptor agonist Ro 64-6198 reduces alcohol self-administration and prevents relapse-like alcohol drinking.
    Kuzmin A; Kreek MJ; Bakalkin G; Liljequist S
    Neuropsychopharmacology; 2007 Apr; 32(4):902-10. PubMed ID: 16880770
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined blockade of both micro - and kappa-opioid receptors prevents the acute orexigenic action of Agouti-related protein.
    Brugman S; Clegg DJ; Woods SC; Seeley RJ
    Endocrinology; 2002 Nov; 143(11):4265-70. PubMed ID: 12399421
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sigma receptor-induced heavy drinking in rats: Modulation by the opioid receptor system.
    Valenza M; Blasio A; DiLeo A; Cottone P; Sabino V
    Pharmacol Biochem Behav; 2020 May; 192():172914. PubMed ID: 32205151
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differences in delta- and mu-opioid receptor blockade measured by positron emission tomography in naltrexone-treated recently abstinent alcohol-dependent subjects.
    Weerts EM; Kim YK; Wand GS; Dannals RF; Lee JS; Frost JJ; McCaul ME
    Neuropsychopharmacology; 2008 Feb; 33(3):653-65. PubMed ID: 17487229
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction of morphine and naltrexone on oral ethanol self-administration in rhesus monkeys.
    Williams KL; Kane EC; Woods JH
    Behav Pharmacol; 2001 Sep; 12(5):325-33. PubMed ID: 11710747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Opioid receptor subtype antagonists differentially alter GABA agonist-induced feeding elicited from either the nucleus accumbens shell or ventral tegmental area regions in rats.
    Khaimova E; Kandov Y; Israel Y; Cataldo G; Hadjimarkou MM; Bodnar RJ
    Brain Res; 2004 Nov; 1026(2):284-94. PubMed ID: 15488491
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of cannabidiol plus naltrexone on motivation and ethanol consumption.
    Viudez-Martínez A; García-Gutiérrez MS; Fraguas-Sánchez AI; Torres-Suárez AI; Manzanares J
    Br J Pharmacol; 2018 Aug; 175(16):3369-3378. PubMed ID: 29859012
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of GABA-B, metabotropic glutamate, and opioid receptor involvement in an animal model of binge drinking.
    Tanchuck MA; Yoneyama N; Ford MM; Fretwell AM; Finn DA
    Alcohol; 2011 Feb; 45(1):33-44. PubMed ID: 20843635
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral ethanol-reinforced responding in rhesus monkeys: effects of opioid antagonists selective for the mu-, kappa-, or delta-receptor.
    Williams KL; Woods JH
    Alcohol Clin Exp Res; 1998 Nov; 22(8):1634-9. PubMed ID: 9835275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extended-release but not immediate-release and subcutaneous methylnaltrexone antagonizes the loperamide-induced delay of whole-gut transit time in healthy subjects.
    Kolbow J; Modess C; Wegner D; Oswald S; Maritz MA; Rey H; Weitschies W; Siegmund W
    J Clin Pharmacol; 2016 Feb; 56(2):239-45. PubMed ID: 26313157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats.
    Mitchell JM; Liang MT; Fields HL
    Psychopharmacology (Berl); 2005 Nov; 182(3):384-92. PubMed ID: 16001119
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dissociation of μ-opioid receptor and CRF-R1 antagonist effects on escalated ethanol consumption and mPFC serotonin in C57BL/6J mice.
    Hwa LS; Shimamoto A; Kayyali T; Norman KJ; Valentino RJ; DeBold JF; Miczek KA
    Addict Biol; 2016 Jan; 21(1):111-24. PubMed ID: 25262980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of baclofen and naltrexone, alone and in combination, on the consumption of palatable food in male rats.
    Avena NM; Bocarsly ME; Murray S; Gold MS
    Exp Clin Psychopharmacol; 2014 Oct; 22(5):460-7. PubMed ID: 25069013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gene transcription alterations associated with decrease of ethanol intake induced by naltrexone in the brain of Wistar rats.
    Oliva JM; Manzanares J
    Neuropsychopharmacology; 2007 Jun; 32(6):1358-69. PubMed ID: 17063152
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combination of Clinically Utilized Kappa-Opioid Receptor Agonist Nalfurafine With Low-Dose Naltrexone Reduces Excessive Alcohol Drinking in Male and Female Mice.
    Zhou Y; Kreek MJ
    Alcohol Clin Exp Res; 2019 Jun; 43(6):1077-1090. PubMed ID: 30908671
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Selective delta-opioid receptor antagonist N,N(CH3)2-Dmt-Tic-OH does not reduce ethanol intake in alcohol-preferring AA rats.
    Ingman K; Salvadori S; Lazarus L; Korpi ER; Honkanen A
    Addict Biol; 2003 Jun; 8(2):173-9. PubMed ID: 12850776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exposure to ethanol on prenatal days 19-20 increases ethanol intake and palatability in the infant rat: involvement of kappa and mu opioid receptors.
    Díaz-Cenzano E; Gaztañaga M; Gabriela Chotro M
    Dev Psychobiol; 2014 Sep; 56(6):1167-78. PubMed ID: 24037591
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ethanol consumption by Fawn-Hooded rats following abstinence: effect of naltrexone and changes in mu-opioid receptor density.
    Cowen MS; Rezvani AH; Jarrott B; Lawrence AJ
    Alcohol Clin Exp Res; 1999 Jun; 23(6):1008-14. PubMed ID: 10397284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone.
    Myers RD; Lankford MF
    Neuropsychopharmacology; 1996 Feb; 14(2):139-49. PubMed ID: 8822536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.